z-logo
Premium
Asymmetric Pentafulvene Carbometalation—Access to Enantiopure Titanocene Dichlorides of Biological Relevance
Author(s) -
Cini Melchior,
Bradshaw Tracey D.,
Woodward Simon,
Lewis William
Publication year - 2015
Publication title -
angewandte chemie
Language(s) - English
Resource type - Journals
eISSN - 1521-3757
pISSN - 0044-8249
DOI - 10.1002/ange.201508034
Subject(s) - enantiopure drug , chemistry , phosphoramidite , cyclopentadienyl complex , enantiomer , stereochemistry , catalysis , enantioselective synthesis , medicinal chemistry , aldol reaction , combinatorial chemistry , organic chemistry , oligonucleotide , dna , biochemistry
Unprecedented asymmetric copper‐catalyzed addition of ZnEt 2 (Z n Bu 2 ) to the exocyclic CC bond of pentafulvenes C 5 H 4 (CHAr) (Ar=2‐MeOPh and related species) results in enantiomerically enriched (up to 93:7 e.r.) cyclopentadienyl ligands (C 5 H 4 CHEtAr; abbreviated Cp R ). Copper catalyst promotion with both chiral phosphoramidite ligands and a phosphate additive is vital in realizing both acceptable enantioselectivities and reaction rates. Enantiomeric Cp R 2 TiCl 2 complexes have been prepared; the ( S , S ) isomer is twice as active towards pancreatic, breast, and colon cancer cell lines as its ( R , R ) enantiomer at 24 h.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom